tradingkey.logo
tradingkey.logo
Search

Microbiotix Finalizes Krw 20 Billion Series B, Securing Korea's First Bacteriophage Clinical Trial

ReutersSep 3, 2025 12:31 PM
facebooktwitterlinkedin
  • MICROBIOTIX FINALIZES KRW 20 BILLION SERIES B, SECURING KOREA'S FIRST BACTERIOPHAGE CLINICAL TRIAL

  • MICROBIOTIX: CUMULATIVE INVESTMENT AMOUNT ACROSS ROUNDS HAS NOW REACHED 29 BILLION KRW

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI